The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques-implications for recombinant vaccine design

Immunogenetics

Volumn 62, Issue 9, 2010, Pages 593-600

  Mudd, Philip A ^a   Piaskowski, Shari M ^a   Neves, Patricia C Costa ^b   Rudersdorf, Richard ^a   Kolar, Holly L ^a   Eernisse, Christopher M ^a   Weisgrau, Kim L ^a   De Santana, Marlon G Veloso ^b   Wilson, Nancy A ^a   Bonaldo, Myrna C ^b   Galler, Ricardo ^c   Rakasz, Eva G ^a,d   Watkins, David I ^a,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Instituto de Technologia em Imunobiologicos   (Brazil)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cytotoxic T lymphocyte; Indian rhesus macaque; Vaccine; Yellow fever 17D

Indexed keywords

ENDOPLASMIC RETICULUM LUMINAL E PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5; PROTEOME; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; YELLOW FEVER VACCINE; YELLOW FEVER VACCINE 17D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RHESUS MONKEY; T LYMPHOCYTE; VACCINATION;

ANIMALS; DRUG DESIGN; MACACA MULATTA; PEPTIDE FRAGMENTS; RNA HELICASES; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL NONSTRUCTURAL PROTEINS; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

FLAVIVIRUS; MACACA MULATTA;

EID: 77957576725     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-010-0461-0     Document Type: Article

References (25)

1. RS Akondy ND Monson JD Miller S Edupuganti D Teuwen H Wu F Quyyumi S Garg JD Altman C Del Rio HL Keyserling A Ploss CM Rice WA Orenstein MJ Mulligan R Ahmed 2009 The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response J Immunol 183 12 7919 7930 1:CAS:528:DC%2BD1MXhsFCkt7jL 10.4049/jimmunol.0803903 19933869
2. MC Bonaldo RC Garratt PS Caufour MS Freire MM Rodrigues RS Nussenzweig R Galler 2002 Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus J Mol Biol 315 4 873 885 1:CAS:528: DC%2BD38XntlKquw%3D%3D 10.1006/jmbi.2001.5258 11812154 (Pubitemid 34729333)
3. MC Bonaldo RC Garratt RS Marchevsky ES Coutinho AV Jabor LF Almeida AM Yamamura AS Duarte PJ Oliveira JO Lizeu LA Camacho MS Freire R Galler 2005 Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface J Virol 79 13 8602 8613 1:CAS:528:DC%2BD2MXlslGis74%3D 10.1128/JVI.79.13.8602-8613.2005 15956601 (Pubitemid 40853559)
4. MC Bonaldo SM Mello GF Trindade AA Rangel AS Duarte PJ Oliveira MS Freire CF Kubelka R Galler 2007 Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes Virol J 4 115 10.1186/1743-422X-4-115 17971212
5. MC Bonaldo MA Martins R Rudersdorf PA Mudd JB Sacha SM Piaskowski PC Costa Neves MG Veloso de Santana L Vojnov C Sr EG Rakasz NA Wilson J Fulkerson JC Sadoff DI Watkins R Galler 2010 Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques J Virol 84 7 3699 3706 1:CAS:528: DC%2BC3cXktFOgur4%3D 10.1128/JVI.02255-09 20089645
6. Fields BN, Knipe DM, Howley PM, Griffin DE (2001) Fields virology. Lippincott Williams & Wilkins, Philadelphia
7. R Galler PR Post CN Santos II Ferreira 1998 Genetic variability among yellow fever virus 17D substrains Vaccine 16 9-10 1024 1028 1:STN:280: DyaK1czkslaktA%3D%3D 10.1016/S0264-410X(97)00278-8 9682354 (Pubitemid 28276018)
8. CS Hahn JM Dalrymple JH Strauss CM Rice 1987 Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it Proc Natl Acad Sci USA 84 7 2019 2023 1:CAS:528:DyaL2sXksFejtbk%3D 10.1073/pnas.84.7.2019 3470774 (Pubitemid 17054141)
9. LA Knapp E Lehmann MS Piekarczyk JA Urvater DI Watkins 1997 A high frequency of Mamu-A01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing Tissue Antigens 50 6 657 661 1:CAS:528:DyaK1cXitlemtw%3D%3D 10.1111/j.1399-0039.1997.tb02927.x 9458122
10. CJ Lai TP Monath 2003 Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis Adv Virus Res 61 469 509 1:CAS:528:DC%2BD2cXhvFOgtbg%3D 10.1016/S0065-3527(03)61013-4 14714441 (Pubitemid 137640957)
11. A Lev MF Princiotta D Zanker K Takeda JS Gibbs C Kumagai E Waffarn BP Dolan A Burgevin P Van Endert W Chen JR Bennink JW Yewdell 2010 Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action Proc Natl Acad Sci USA 107 15 6964 6969 1:CAS:528:DC%2BC3cXltFSjsbg%3D 10.1073/pnas.0910997107 20351281
12. JT Loffredo J Sidney C Wojewoda E Dodds MR Reynolds G Napoe BR Mothe DH O'Connor NA Wilson DI Watkins A Sette 2004 Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A02, and potential escape from CTL recognition J Immunol 173 8 5064 5076 1:CAS:528:DC%2BD2cXotFCqu78%3D 15470050
13. JT Loffredo BJ Burwitz EG Rakasz SP Spencer JJ Stephany JP Vela SR Martin J Reed SM Piaskowski J Furlott KL Weisgrau DS Rodrigues T Soma G Napoe TC Friedrich NA Wilson EG Kallas DI Watkins 2007 The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape J Virol 81 6 2624 2634 1:CAS:528: DC%2BD2sXjt1GrsLk%3D 10.1128/JVI.01912-06 17192314 (Pubitemid 46447028)
14. GP Mateu RS Marchevsky F Liprandi MC Bonaldo ES Coutinho M Dieudonne E Caride AV Jabor MS Freire R Galler 2007 Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus Trans R Soc Trop Med Hyg 101 3 289 298 1:CAS:528:DC%2BD2sXjs1GmtL0%3D 10.1016/j.trstmh.2006.08.006 17169387 (Pubitemid 46039444)
15. A McAllister AE Arbetman S Mandl C Pena-Rossi R Andino 2000 Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases J Virol 74 19 9197 9205 1:CAS:528:DC%2BD3cXmslymtL4%3D 10.1128/JVI.74.19.9197-9205.2000 10982366
16. B Peters HH Bui J Sidney Z Weng JT Loffredo DI Watkins BR Mothe A Sette 2005 A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules Vaccine 23 45 5212 5224 1:CAS:528:DC%2BD2MXhtFWmsr3M 10.1016/j.vaccine.2005.07.086 16137805 (Pubitemid 41443427)
17. JD Poland CH Calisher TP Monath WG Downs K Murphy 1981 Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine Bull World Health Organ 59 6 895 900 1:STN:280:DyaL387mt1ynug%3D%3D 6978196
18. KV Pugachev F Guirakhoo TP Monath 2005 New developments in flavivirus vaccines with special attention to yellow fever Curr Opin Infect Dis 18 5 387 394 10.1097/01.qco.0000178823.28585.ad 16148524
19. B Pulendran J Miller TD Querec R Akondy N Moseley O Laur J Glidewell N Monson T Zhu H Zhu S Staprans D Lee MA Brinton AA Perelygin C Vellozzi PJ Brachman S Lalor D Teuwen RB Eidex M Cetron F Priddy C del Rio J Altman R Ahmed 2008 Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes J Infect Dis 198 4 500 507 10.1086/590187 18598196
20. TD Querec RS Akondy EK Lee W Cao HI Nakaya D Teuwen A Pirani K Gernert J Deng B Marzolf K Kennedy H Wu S Bennouna H Oluoch J Miller RZ Vencio M Mulligan A Aderem R Ahmed B Pulendran 2009 Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans Nat Immunol 10 1 116 125 1:CAS:528:DC%2BD1cXhsVWhu73J 10.1038/ni.1688 19029902
21. CT Stoyanov SB Boscardin S Deroubaix G Barba-Spaeth D Franco RS Nussenzweig M Nussenzweig CM Rice 2010 Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii Vaccine 28 29 4644 4652 1:CAS:528:DC%2BC3cXntlansbw%3D 10.1016/j.vaccine.2010.04.071 20451637
22. D Tao G Barba-Spaeth U Rai V Nussenzweig CM Rice RS Nussenzweig 2005 Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model J Exp Med 201 2 201 209 1:CAS:528:DC%2BD2MXot12msQ%3D%3D 10.1084/jem.20041526 15657290 (Pubitemid 40189429)
23. RG van Der Most K Murali-Krishna R Ahmed JH Strauss 2000 Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response J Virol 74 17 8094 8101 10.1128/JVI.74.17. 8094-8101.2000 (Pubitemid 30641655)
24. JW Yewdell LC Anton JR Bennink 1996 Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol 157 5 1823 1826 1:CAS:528:DyaK28XltFygtr8%3D 8757297
25. Yusim K, Korber BTM, Brander C, Haynes BF, Koup R, Moore JP, Walker BD, Watkins DI (2009) HIV Molecular Immunology 2009. Theoretical Biology and Biophysics, Los Alamos